Evert (Eef) Schimmelpennink

Schimmelpinnink leads LENZ Therapeutics, a late-stage clinical company developing innovative, ophthalmic pharmaceutical products. Previously, he was CEO and president of Pfenix Inc, and served as CEO for Alvotech. He currently serves on the board for iBio Inc..

  • March 2022

Added to: Pipeline Therapeutics - San Diego, CA

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration.